Physician profile
Richard E Blalock
NPI 1295723328
$1,422.39
in general payments reported to CMS, 2019-2025
22 companies · $77.59 in 2025
The $77.59 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $67.74 · 2021: $122 · 2022: $196 · 2023: $276 · 2024: $175 · 2025: $77.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.70 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Amgen INC. | $207.37 | 2019-2022 | |
| Pfizer INC. | $200.09 | 2019-2023 | |
| Allergan, INC. | $136.20 | 2019 | |
| Medtronic, INC. | $65.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $53.01 | 2022-2023 | |
| Astellas Pharma US INC | $46.78 | 2022-2023 | Myrbetriq, Veozah |
| Janssen Pharmaceuticals, INC | $41.94 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $30.00 | 2019 | |
| Phathom Pharmaceuticals, INC. | $25.63 | 2024 | Voquezna |
| Si-Bone, INC. | $22.26 | 2019 | |
| Abbott Laboratories | $21.41 | 2021 | |
| Lilly USA, LLC | $20.73 | 2025 | Kisunla |
| Philips North America LLC | $17.58 | 2024 | (Ck4) Mcot |
| Tris Pharma INC | $17.14 | 2025 | Onyda Xr |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.32 | 2023 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.42 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $14.16 | 2023 | |
| Lundbeck LLC | $14.07 | 2023 | Vyepti |
| Hologic Sales and Service, LLC | $13.61 | 2022 | |
| Novo Nordisk INC | $11.88 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Blalock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.